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Summary box
 ► Epidemics are a gendered vulnerability, with their 
socioeconomic impact disproportionately high 
among women, even when, as it seems the case 
with COVID-19, mortality is higher among men.
 ► However, women are not only a vulnerable popu-
lation, they can serve as agents of change whose 
contributions can improve epidemic response and 
recovery.
 ► In COVID-19 response and recovery, existing lack 
of diversity and gender representation in decision- 
making means perspectives of some of the most 
vulnerable communities are left out.
 ► The evidence and lessons from peace, disaster and 
business sectors suggest that lack of diversity and 
failing to leverage women’s expertise and talent in 
decision- making can limit an effective response.
 ► In addition to being ethical, diverse and gender in-
clusive decision- making will yield innovation and 
knowledge dividends, limit group- think and promote 
greater accountability for an adaptive response and 
resilient recovery to COVID-19.
Epidemics function as a gendered vulnera-
bility, and yet gender remains an afterthought 
in health security and pandemic response, 
including to coronavirus disease 2019 
(COVID-19).1 Emerging data indicate that 
COVID-19 mortality is greater among men, 
but past experiences suggest that the socio-
economic impact of epidemics tends to be 
far greater for women. As a result, it is essen-
tial to assess the intersectional and gendered 
vulnerabilities in health emergencies. In addi-
tion, given the gender- skewed landscape of 
power and decision- making in global health, 
it is also critical to outline women’s leadership 
and role in such contexts.
Women are users of health services, and 
they are agents of change in health, making 
critical contributions as parents, front- line 
responders, health promoters, influencers, 
researchers, scientists and decision- makers. 
In China’s COVID-19 response, female nurses 
and community health workers were the first 
line of defence against the outbreak.1 Despite 
their major role, an interplay of power and 
privilege often results in women—particu-
larly women from minority ethnic groups—
being under- represented in health and 
humanitarian leadership, even when women 
and such minorities are disproportionately 
affected. This is similarly the case for women 
from other under- represented groups such as 
indigenous people, in low and middle- income 
countries (LMIC) and sexual minorities or 
lesbian, gay, bisexual, transgender, queer and 
intersex (LGBTQI) individuals.
Regardless of constituting over 70% of the 
global health workforce, women hold only 
25% of leadership roles in health.2 Further, 
women’s scientific expertise is often excluded 
in the public realm even though they are 
more engaged in science outreach.3 The 
imbalance in diversity and equity, at the inter-
section of gender and LMIC representation, 
is also mirrored in publications and editorial 
boards of major global health journals.4 5 A 
recent breakdown of WHO Expert Advisory 
Panels shows that only 34% of members were 
women and only 11% of members were from 
the African region, compared with 29% of 
members from the European region.6 These 
patterns of inequality in decision- making are 
then reflected in who sets the research prior-
ities that inform policy, and who makes the 
policy decisions in COVID-19 response and 
recovery.
The lack of representation in agenda setting 
and decision- making matters because women 
face a triple burden in pandemics—high risk 
of exposure to nosocomial infections in their 
role as healthcare workers; lost opportunities 
due to school closures and increased unpaid 
family care; and heightened risk of ill health 
due to diverted resources and the cascading 
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Figure 1 How greater gender representation and diversity in decision- making strengthens COVID-19 and other epidemic 
responses. GBV, Gender- Based Violence.
effects of pandemics.1 In the context of COVID-19, 
women and sexual minorities can also face a higher risk 
of Gender- Based Violence (GBV). Additionally, women 
constitute a majority of workers in the non- agricultural 
informal sector7—leaving them vulnerable to loss of live-
lihood and economic insecurity due to the disruptive 
‘fearonomic effects’ of pandemics.8 The socioeconomic 
impact of disasters and crises is further exacerbated 
for women in minority and lower income groups.9 As 
mothers, women are more likely to be responsible for 
nearly 1.5 billion children who are out of school in times 
of widespread school disruptions—drastically impacting 
their ability to be financially independent.10
Epidemics further exacerbate other profound secu-
rity, mental health and health risks in countries facing 
protracted conflicts with widespread gender inequality 
and general societal and economic disruption, due to 
weakened infrastructure and reduced access to health 
services. Lack of diversity and gender representation in 
decision- making at global, country and organisational 
levels means perspectives of some of the most vulnerable 
communities—including refugees and migrants, ethnic 
and sexual minorities—are often left out, limiting an 
effective response by failing to address the direct and 
indirect effects on women and girls and minorities, and 
failing to leverage their expertise and talent when it is 
needed most.
Gender- equal representation is more than just a moral 
imperative. When gender representation moves beyond 
pure symbolism, it leads to smarter, ethical and more 
effective decision- making—especially in crises. Evidence 
from peace and security studies shows that although peace 
processes led by women were 35% more likely to last, less 
than 13% of peace negotiators selected are women.11 
Inclusion of women in decision- making advances stability 
and security, community trust and financial account-
ability, and focuses more on reducing inequities. Addi-
tionally, evidence from the business sector highlights 
the strong association of gender diversity with innovative 
and ethical decision- making, and with reduction in fraud 
and cognitive biases.12–15 Greater gender representa-
tion brings with it diverse perspectives and approaches 
to problem solving, resulting in faster and better quality 
decisions.16 17
For epidemic response to be effective and adaptive, 
perspectives of women, and LMICs and vulnerable 
communities are critical. Interventions that work in high- 
income countries may not work elsewhere. For example, 
border closures will have limited applicability in coun-
tries with porous borders, and top- down interventions 
may be less effective in countries where the community 
trust in governments is lower, particularly in areas where 
women have been mistreated by police and armed forces. 
Insights from the implementation of interventions in 
LMICs (for COVID-19 and previous disease outbreaks) 
and country- specific context that takes into perspec-
tives of women, and vulnerable communities can greatly 
inform the COVID-19 response and recovery. A diverse 
decision- making body for health security and COVID-19 
response, with expertise from LMICs, women, patient 
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groups, indigenous people and the LGBTQI community, 
will limit group- think, boost problem solving, account-
ability and learning to unleash overlooked and innova-
tive context- appropriate solutions to global challenges.
The same people who are engaged in response today 
will be the ones leading recovery and preparedness 
efforts tomorrow. Measures to promote gender equity, 
and representation in decision- making at all levels such 
as those proposed in the ‘COVID 50/50 Five Asks for 
Gender- Responsive Health Security’ will strengthen both 
global and local COVID-19 efforts and ensure greater 
engagement of those who are most affected in planning 
of response and recovery.18 In addition, mainstreaming 
gender in data collection and policy instruments such as 
the Joint External Evaluations and greater inclusion of 
women—particularly women from LMICs—in decision- 
making at the global level and in public discourse will 
ensure that we reap the innovation and knowledge divi-
dends through smarter and creative decision- making 
for an effective COVID-19 response and a resilient post- 
COVID-19 future (see figure 1).
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